Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure скачать в хорошем качестве

Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure

Novo Nordisk CEO Mike Doustdar tells CNBC that Medicare coverage for obesity treatments, as well as the launch of a new obesity pill, should help boost prescription volumes and offset lower prices. Chapters: 00:00 Introduction 00:31 Novo Nordisk’s 2026 Outlook  6:51 EU Regulations 12:36 DOJ and FDA Support 14:41 Medical Coverage 20:00 Market share Reporter: Annika Kim Constantino Producer: Darren Geeter Senior Managing Producer: Tala Hadavi Camera by: Tara McCurrie and Shawn McMillan Audio by: Francesco LoCascio For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC on Threads: https://cnb.cx/threads Follow CNBC News on X: https://cnb.cx/FollowCNBC Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC https://www.cnbc.com/select/best-cred... #CNBC #CNBCTV Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure